Biotech Target N V - Oct 21, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Stock symbol: MGNX
Transactions as of: Oct 21, 2022
Transactions value $: $2,247,600
Form type: 4
Date filed: 10/25/2022, 04:19 PM
Previous filing: Oct 21, 2022
Next filing: Nov 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$1.16M	+250K	+3.23%	$4.63	7.98M	Oct 21, 2022	Direct
transaction	MGNX	Common Stock	Purchase	$1.09M	+250K	+3.13%	$4.36	8.23M	Oct 24, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.